MET Tops Q1 EPS Estimates on Strong Investment Income and Volume Growth
📈 MetLife reported first-quarter 2026 adjusted operating EPS of $2.42, beating analyst estimates by 7.6% and growing 23% year over year.
💰 Adjusted operating revenues increased 4.5% to $19.7 billion, surpassing the consensus mark by 2.4%.
📉 Strong performance was driven by improved net investment income, favorable underwriting, and solid business volume growth across segments.
⚠️ Upside was partially offset by higher expenses, unfavorable tax items in Latin America, and a wider-than-expected loss in the Corporate & Other unit.
💵 Adjusted PFOs reached $13.3 billion, rising 10% year over year when excluding pension risk transfer transactions.
📊 Net investment income grew 5% to $5.5 billion due to asset growth and improved variable investment performance.
🏥 Group Benefits posted adjusted earnings of $439 million, a 19% increase driven by better underwriting and volume growth.
🌏 International segments including RIS, Asia, Latin America, and EMEA all reported double-digit or strong single-digit earnings growth.
💼 MetLife Investment Management saw adjusted earnings surge 68%, though it missed the consensus estimate by 9.2%.
⚠️ Corporate & Other unit incurred an adjusted loss of $177 million, which was wider than the prior year's $129 million loss.
💰 Total expenses rose 2% to $17.6 billion due to increased policyholder benefits and claims costs.
📉 The adjusted expense ratio deteriorated 30 basis points to 20.3%, excluding notable items and PRT adjustments.
⚖️ Net income climbed 29.7% to $1.1 billion, while adjusted return on equity improved to 17%.
💵 Cash and cash equivalents stood at $22.7 billion, up from $22 billion at the end of 2025.
📉 Total assets remained relatively stable at $743.2 billion compared to $745.2 billion at the end of 2025.
💳 Long-term debt decreased slightly to $14.4 billion, while equity totalled $27.6 billion down from $28.7 billion.
🔄 Share buybacks amounted to $750 million in Q1 and approximately $200 million in April 2026.
💸 Dividends paid included $350 million for the quarter under review, with book value per share up 7.8% to $37.92.
- MetLife reported first-quarter adjusted EPS of $2.42, beating the Zacks Consensus Estimate by 7.6% with a full-year bottom line advance of 23%.
- Adjusted operating revenues improved 4.5% year over year to $19.7 billion, surpassing consensus expectations by 2.4%.
- Net investment income grew 5% year over year to $5.5 billion driven by asset growth and improved variable income.
- Group Benefits segment earnings rose 19% year-over-year to $439 million, exceeding analyst estimates by 22.5% on strong underwriting results.
- RIS unit adjusted earnings advanced 11% year-over-year to $451 million with a significant 58% increase in Adjusted PFOs excluding pension risk transfers.
- Asia segment saw adjusted earnings surge 31% year-over-year to $487 million, supported by volume growth and improved investment income.
- Latin America delivered strong reported Adjusted PFO growth of 25% year-over-year to $1.9 billion driven by solid business growth and persistency.
- EMEA segment recorded a robust 33% year-over-year earnings advance to $110 million fueled by strong volumes and policy renewals.
- MetLife Investment Management experienced impressive 68% year-over-year earnings growth to $47 million on back of strong business expansion.
- Company cash position strengthened with $22.7 billion in cash and equivalents, up from $22 billion at the end of 2025.
- Book value per share increased 7.8% year-over-year to $37.92 as of March 31, 2026.
- Management demonstrated confidence with an expectation of double-digit adjusted EPS growth in the near term.
- Higher expenses and unfavorable tax-related items in Latin America partially offset earnings growth.
- The loss in the Corporate & Other unit widened to $177 million from $129 million in the prior year quarter.
- MetLife's Metlife Investment Management segment missed its Zacks Consensus Estimate by 9.2%.
- Total assets declined year over year, dropping from $745.2 billion at the end of 2025 to $743.2 billion as of March 31, 2026.
- Total equity contracted from $28.7 billion to $27.6 billion despite share buybacks and dividend payments.
- MetLife has raised the expense ratio forecast to 12.1%, indicating potential cost pressures ahead.
- Management maintains expectations for a pre-tax variable investment income of around $1.6 billion for 2026, which is below the growth trajectory implied by prior years' results.
